GleamWall
中文EN

APT ALPHA PRO TECH LTD

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 884269 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.8%
TTM net income YoY40.0%
TTM EPS YoY44.1%
Revenue 3-yr CAGR3.1%
Net income 3-yr CAGR11.7%

Margins

Gross margin38.6%
Operating margin8.7%
Net margin8.1%
FCF margin14.2%
EBITDA margin10.2%

Returns

ROE8.0%
ROA6.7%
ROIC (approx.)10.2%
Asset turnover0.83x

Leverage & solvency

Liabilities / assets17.2%
Debt / equity0.00x
Current ratio8.71x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.87x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$16.60M$18.67M$14.59M$13.86M$14.79M$16.67M$13.82M$13.82M
Cost of revenue$9.67M$11.70M$9.07M$8.72M$8.92M$10.54M$8.43M$8.63M
Gross profit$6.94M$6.98M$5.52M$5.15M$5.87M$6.13M$5.39M$5.19M
SG&A expense$4.74M$4.70M$4.69M$3.96M$4.57M$4.56M$4.69M$4.38M
Operating income$1.97M$2.01M$580,000$952,000$1.10M$1.33M$455,000$674,000
Income tax$605,000$558,000$183,000$295,000$317,000$367,000$159,000$233,000
Net income$1.93M$1.83M$702,000$698,000$976,000$1.24M$613,000$847,000
EBITDA$2.20M$2.28M$830,000$1.19M$1.30M$1.57M$698,000$813,000
EPS (basic)0.190.180.07—0.090.120.06—
EPS (diluted)0.190.180.07—0.090.120.06—
Weighted avg. shares (diluted)10.37M10.35M10.33M—10.49M10.61M10.84M—
Balance sheet
Cash & equivalents$25.55M$18.90M$16.88M$16.99M$17.66M$14.46M$13.35M$18.64M
Inventory$17.85M$18.65M$22.05M$23.60M$23.48M$22.36M$23.57M$22.73M
Current assets$58.82M$54.19M$51.89M$52.52M$51.75M$50.54M$49.34M$50.64M
PP&E, net$7.83M$7.97M$8.10M$8.23M$8.21M$8.31M$8.41M$8.52M
Goodwill$55,000$55,000$55,000$55,000$55,000$55,000$55,000$55,000
Total assets$79.74M$75.35M$72.98M$74.13M$73.87M$73.17M$72.18M$73.74M
Current liabilities$6.75M$3.18M$2.62M$4.06M$3.67M$3.02M$2.31M$3.12M
Total liabilities$13.73M$10.43M$9.97M$11.65M$11.33M$10.92M$10.45M$11.51M
Shareholders' equity$66.01M$64.92M$63.01M$62.48M$62.54M$62.25M$61.73M$62.23M
Shares outstanding10.18M10.12M10.13M10.13M10.28M10.41M10.60M10.82M
Cash flow statement
Operating cash flow$7.11M$2.21M$12,000$318,000$3.92M$2.09M-$3.96M$2.41M
Capital expenditure$83,000$142,000$117,000$267,000$99,000$138,000$135,000$1.44M
Free cash flow$7.03M$2.07M-$105,000$51,000$3.82M$1.95M-$4.09M$970,000
Investing cash flow-$83,000-$142,000-$117,000-$267,000-$99,000-$138,000-$135,000-$1.44M
Financing cash flow-$384,000-$53,000$0-$721,000-$630,000-$838,000-$1.19M-$728,000
Depreciation & amortization$226,000$268,000$250,000$239,000$203,000$240,000$243,000$139,000
Stock-based compensation$126,000$127,000$132,000$132,000$136,000$136,000$136,000$136,000
Share buybacks$384,000$99,000$0$713,000$624,000$830,000$1.18M$721,000

Free plan shows the latest 8 periods; Pro shows all 68 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.